Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium Difficile-associated Diarrhea (CDAD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Large-scale testing (Phase 3)Study completedNCT01987895
What this trial is testing

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea

Who this might be right for
Clostridium Difficile Infection
Actelion 632
Testing effectiveness (Phase 2)Study completedNCT00097422
What this trial is testing

OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Diarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Testing effectiveness (Phase 2)Study completedNCT04247542
What this trial is testing

ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Acurx Pharmaceuticals Inc. 53
Not applicableLooking for participantsNCT06839209
What this trial is testing

Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated Diarrhea

Who this might be right for
Clostridium; Difficile, As Cause of Disease Classified ElsewhereClostridium Difficile Diarrhea
ABResearch S.r.l. 18
Large-scale testing (Phase 3)Ended earlyNCT00466635
What this trial is testing

Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea

Who this might be right for
Enterocolitis, PseudomembranousDiarrheaClostridium Difficile
Genzyme, a Sanofi Company 65
Large-scale testing (Phase 3)Study completedNCT00314951
What this trial is testing

Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)

Who this might be right for
Clostridium InfectionsDiarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 629
Large-scale testing (Phase 3)Study completedNCT02218372
What this trial is testing

Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile-associated Diarrhea (CDAD)
Astellas Pharma Europe B.V. 148
Large-scale testing (Phase 3)Study completedNCT00269399
What this trial is testing

A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Clostridium InfectionsDiarrhea
Bausch Health Americas, Inc. 237
Testing effectiveness (Phase 2)Study completedNCT01591863
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile-associated Diarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 38
Early research (Phase 1)Study completedNCT02835105
What this trial is testing

Ascending Single Doses of Surotomycin in Healthy Participants (MK-4261-008)

Who this might be right for
Clostridium Difficile Associated Diarrhea (CDAD)
Merck Sharp & Dohme LLC 40
Testing effectiveness (Phase 2)Study completedNCT00382304
What this trial is testing

The Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea

Who this might be right for
Pseudomembranous ColitisClostridium Difficile DiarrheaAntibiotic-Associated Diarrhea
Genzyme, a Sanofi Company 24
Testing effectiveness (Phase 2)Study completedNCT01559545
What this trial is testing

A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis

Who this might be right for
Clostridium Difficile Associated Diarrhea
Dr. Reddy's Laboratories Limited 60
Post-approval studies (Phase 4)Ended earlyNCT04003818
What this trial is testing

Efficacy and Safety of Teicoplanin in CDAD

Who this might be right for
Clostridium Difficile Infection-associated Diarrhea and Colitis
Sanofi 50
Large-scale testing (Phase 3)Study completedNCT02179658
What this trial is testing

Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile
Astellas Pharma Inc 210
Large-scale testing (Phase 3)Study completedNCT01597505
What this trial is testing

Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005)

Who this might be right for
Clostridium Difficile Infection
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 606
Large-scale testing (Phase 3)Ended earlyNCT01143272
What this trial is testing

Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea

Who this might be right for
Antibiotic-associated DiarrheaClostridium DifficileDiarrhea
Bernhard Nocht Institute for Tropical Medicine 477
Testing effectiveness (Phase 2)Study completedNCT01232595
What this trial is testing

Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections

Who this might be right for
Moderate Clostridium Difficile Infection
Novartis Pharmaceuticals 109
Large-scale testing (Phase 3)Study completedNCT01691248
What this trial is testing

Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001)

Who this might be right for
Clostridium Difficile-Associated Diarrhea (CDAD)
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 611